See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 28, 2008

Liver Cancer Epilepsy Women's Health

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Liver Cancer

If you are an adult with cancer confined to the liver (hepatocellular carcinoma) that is not suitable for surgical removal, you may be eligible to participate in this study.

The research site is in Charlottesville, Va.

More information

Please see http://www.centerwatch.com/patient/studies/cat197.html.

-----

Epilepsy

Person between the ages of 16 and 75 years who have both inclusive, well-characterized focal epilepsy or epileptic syndrome may be eligible for this study.

Other requirements include having at least 2 --and not exceeding 40 -- partial onset seizures, whether or not they are secondarily generalized per 4 weeks during the 8-week baseline period; being on a stable dose of at least 1 but no more than 2 concomitant AEDs with the second AED 50 percent of the minimum recommended maintenance dose.

The research site is in Atlanta, Ga.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Women's Health

Menopausal women between the ages 45 and 55 may qualify for this study if they have either more than 4 hot flashes each day or no hot flashes at all.

The research site is in Boston, Mass.

More information

Please see http://www.centerwatch.com/patient/studies/cat438.html.

-----

Copyright 2008 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.